Otonomy to Present at Cowen and Company Health Care Conference
Back to JobsSAN DIEGO , Feb. 28, 2017 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced that David A. Weber , Ph.D., president and chief executive
Apply Now